Zeaxanthin prevents ferroptosis by promoting mitochondrial function and inhibiting the p53 pathway in free fatty acid-induced HepG2 cells.

[1]  A. O’Halloran,et al.  Plasma lutein and zeaxanthin concentrations associated with musculoskeletal health and incident frailty in The Irish Longitudinal Study on Ageing (TILDA) , 2022, Experimental Gerontology.

[2]  W. Gu,et al.  p53 in ferroptosis regulation: the new weapon for the old guardian , 2022, Cell Death & Differentiation.

[3]  Z. Zuo,et al.  Mitochondria damage and ferroptosis involved in Ni-induced hepatotoxicity in mice. , 2021, Toxicology.

[4]  Mingzhu Zheng,et al.  Zeaxanthin ameliorates obesity by activating the β3-adrenergic receptor to stimulate inguinal fat thermogenesis and modulating the gut microbiota. , 2021, Food & function.

[5]  Xia Li,et al.  p53: A Double-Edged Sword in Tumor Ferroptosis. , 2021, Pharmacological research.

[6]  R. Weiskirchen,et al.  The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases. , 2021, Clinica chimica acta; international journal of clinical chemistry.

[7]  Yulong Chen,et al.  Ferroptosis as a new therapeutic opportunity for nonviral liver disease. , 2021, European journal of pharmacology.

[8]  Zifeng Huang,et al.  Niujiaodihuang Detoxify Decoction inhibits ferroptosis by enhancing glutathione synthesis in acute liver failure models. , 2021, Journal of ethnopharmacology.

[9]  R. Liu,et al.  Goji berry (Lycium spp.) extracts exhibit antiproliferative activity via modulating cell cycle arrest, cell apoptosis, and the p53 signaling pathway. , 2021, Food & function.

[10]  C. Hölscher,et al.  Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis , 2021, Journal of Natural Medicines.

[11]  A. Belaidi,et al.  Ferroptosis: mechanisms and links with diseases , 2021, Signal Transduction and Targeted Therapy.

[12]  L. Zhuang,et al.  Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy , 2020, Protein & Cell.

[13]  X. Shan,et al.  Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease. , 2020, Toxicology.

[14]  N. Sata,et al.  Ferroptosis driven by radical oxidation of n-6 polyunsaturated fatty acids mediates acetaminophen-induced acute liver failure , 2020, Cell Death & Disease.

[15]  Can Liu,et al.  Mitochondria regulation in ferroptosis. , 2019, European journal of cell biology.

[16]  T. Efferth,et al.  Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK/SIRT1 signaling pathway in HepG2 cells. , 2019, European journal of pharmacology.

[17]  Xinting Sun,et al.  Theaflavic acid from black tea protects PC12 cells against ROS-mediated mitochondrial apoptosis induced by OGD/R via activating Nrf2/ARE signaling pathway , 2019, Journal of Natural Medicines.

[18]  T. Vanden Berghe,et al.  Targeting Ferroptosis to Iron Out Cancer. , 2019, Cancer cell.

[19]  H. Nakano,et al.  Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis , 2019, Cell Death & Disease.

[20]  K. Christensen,et al.  Dietary Carotenoids and Non-Alcoholic Fatty Liver Disease among US Adults, NHANES 2003–2014 , 2019, Nutrients.

[21]  Mingzhu Zheng,et al.  Zeaxanthin promotes mitochondrial biogenesis and adipocyte browning via AMPKα1 activation. , 2019, Food & function.

[22]  Minghui Gao,et al.  Role of Mitochondria in Ferroptosis. , 2019, Molecular cell.

[23]  Bumseok Kim,et al.  Ferroptosis affects the progression of non-alcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice. , 2019, The American journal of pathology.

[24]  Miao Sui,et al.  Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  Li Ma,et al.  Total sesquiterpene glycosides from Loquat (Eriobotrya japonica) leaf alleviate high-fat diet induced non-alcoholic fatty liver disease through cytochrome P450 2E1 inhibition. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[26]  F. Akhlaghi,et al.  Non-alcoholic fatty liver disease (NAFLD) – pathogenesis, classification, and effect on drug metabolizing enzymes and transporters , 2017, Drug metabolism reviews.

[27]  G. Liew,et al.  Lutein and Zeaxanthin—Food Sources, Bioavailability and Dietary Variety in Age-Related Macular Degeneration Protection , 2017, Nutrients.

[28]  W. Gu,et al.  Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression. , 2016, Cell reports.

[29]  W. Gu,et al.  Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses , 2016, Proceedings of the National Academy of Sciences.

[30]  E. Tsochatzis,et al.  The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). , 2016, Metabolism: clinical and experimental.

[31]  S. Dixon,et al.  Mechanisms of ferroptosis , 2016, Cellular and Molecular Life Sciences.

[32]  W. Gu,et al.  Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses , 2015, Cell cycle.

[33]  Li-ping Hao,et al.  Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats. , 2015, World journal of gastroenterology.

[34]  W. Gu,et al.  Ferroptosis as a p53-mediated activity during tumour suppression , 2015, Nature.

[35]  C. Byrne,et al.  NAFLD: a multisystem disease. , 2015, Journal of hepatology.

[36]  F. Nassir,et al.  Role of Mitochondria in Nonalcoholic Fatty Liver Disease , 2014, International journal of molecular sciences.

[37]  Matthew E. Welsch,et al.  Regulation of Ferroptotic Cancer Cell Death by GPX4 , 2014, Cell.

[38]  R. Xavier,et al.  Autosis is a Na+,K+-ATPase–regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia–ischemia , 2013, Proceedings of the National Academy of Sciences.

[39]  P. Barberger‐Gateau,et al.  Association of macular pigment density with plasma ω-3 fatty acids: the PIMAVOSA study. , 2012, Investigative ophthalmology & visual science.

[40]  L. N. Valenti,et al.  Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study. , 2011, QJM : monthly journal of the Association of Physicians.

[41]  H. Tilg,et al.  Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis , 2010, Hepatology.

[42]  B. Neuschwander‐Tetri,et al.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. , 2010, The New England journal of medicine.

[43]  F. Murray-Zmijewski,et al.  A complex barcode underlies the heterogeneous response of p53 to stress , 2008, Nature Reviews Molecular Cell Biology.

[44]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[45]  Susan E Hankinson,et al.  The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview. , 2002, The Journal of nutrition.

[46]  M. Tso,et al.  Absorption and tissue distribution of zeaxanthin and lutein in rhesus monkeys after taking Fructus lycii (Gou Qi Zi) extract. , 2001, Investigative ophthalmology & visual science.

[47]  D. Snodderly,et al.  Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. , 2000, The American journal of clinical nutrition.